Med Page Today
SEPTEMBER 30, 2024
(MedPage Today) -- A new diagnosis of Alzheimer's disease or related dementia was more common after falls than after other traumatic injuries, an analysis of Medicare claims data showed. The study assessed nearly 2.5 million older adults who had.
Science Daily - Stroke
SEPTEMBER 30, 2024
Frequent drinking of fizzy drinks or fruit juice is associated with an increased risk of stroke, according to new findings. The research also found that drinking more than four cups of coffee per day also increases the risk of stroke.
Med Page Today
SEPTEMBER 30, 2024
(MedPage Today) -- Kids born via assisted reproductive technology (ART) had higher risk of congenital heart defects (CHDs), though the absolute risk difference was small, an observational Nordic study of 7.7 million children found. Major CHDs.
Science Daily - Heart Disease
SEPTEMBER 30, 2024
People who have been fully vaccinated against COVID-19 have a significantly lower risk of developing more severe cardiovascular conditions linked to COVID-19 infection, according to a new Swedish study. At the same time, some cardiovascular effects are seen after individual doses of the vaccine.
Speaker: Simran Kaur, Co-founder & CEO at Tattva Health Inc.
AI is transforming clinical trials—accelerating drug discovery, optimizing patient recruitment, and improving data analysis. But its impact goes far beyond research. As AI-driven innovation reshapes the clinical trial process, it’s also influencing broader healthcare trends, from personalized medicine to patient outcomes. Join this new webinar featuring Simran Kaur for an insightful discussion on what all of this means for the future of healthcare!
Science Daily - Stroke
SEPTEMBER 30, 2024
Researchers have developed a laser-based device that can measure blood flow noninvasively and differentiate stroke risk based on current physiological conditions.
Science Daily - Heart Disease
SEPTEMBER 30, 2024
Scientists discovered that blocking the activity of the hormone glucagon could treat a common and challenging type of heart failure that affects millions worldwide.
Cardiovascular Update brings together the best content for cardiovascular medicine professionals from the widest variety of industry thought leaders.
Science Daily - Heart Disease
SEPTEMBER 30, 2024
Heart transplant patients who live in socioeconomically disadvantaged areas are more likely to experience post-surgical complications and die within five years than patients who live in more advantaged areas, even when those patients were transplanted at topnotch high-volume hospitals.
HCPLive
SEPTEMBER 30, 2024
A study found pregnant patients with IgA nephropathy and adverse pregnancy outcomes were less likely to achieve proteinuria remission, though renal function remained unaffected.
Med Page Today
SEPTEMBER 30, 2024
(MedPage Today) -- There may be a future for cardiac myosin inhibitors in heart failure with preserved ejection fraction (HFpEF), according to the proof-of-concept EMBARK-HFpEF trial. An established cardiac myosin inhibitor for hypertrophic cardiomyopathy.
Dr. Paddy Barrett
SEPTEMBER 30, 2024
"Frustrated, lost and confused." That was the main feedback I got from thousands of readers when I asked them about their experience working with existing healthcare systems to implement a plan to prevent heart disease. This is not good. Heart disease is the leading cause of death worldwide, and with the right approaches, 80% or more can be prevented at an early age.
NEJM Journal Watch - Cardiology
SEPTEMBER 30, 2024
A 14-day monitor detected more atrial fibrillation but did not affect hospitalization rates for stroke or hemorrhage.
American College of Cardiology
SEPTEMBER 30, 2024
Computed tomography (CT) relies on the passage and attenuation of X-ray photons to create an image.
HCPLive
SEPTEMBER 30, 2024
Family Heart Foundation announces the launch of Cholesterol Connect, a program that provides free at-home lipid screening and personalized support.
American College of Cardiology
SEPTEMBER 30, 2024
In this episode of CardiaCast, world-renowned hypertrophic cardiomyopathy (HCM) expert Dr. Matthew Martinez will discuss with Dr. Cesar Herrera challenges that exist in Latin America related to the application of the recently issued guideline, “2024 AHA/ACC/AMSSM/HRS/PACES/SCMR Guideline for the Management of Hypertrophic Cardiomyopathy: A Report of the American Heart Association/American College of Cardiology Joint Committee on Clinical Practice Guidelines.
HCPLive
SEPTEMBER 30, 2024
Ascendis Pharma has submitted a sBLA to the FDA for TransCon hGH for the treatment of adults with growth hormone deficiency.
Science Daily - Heart Disease
SEPTEMBER 30, 2024
A new study also shows imaging for early detection and monitoring can improve prediction and prevention of premature death.
Med Page Today
SEPTEMBER 30, 2024
(MedPage Today) -- Secondary efficacy analyses of the pivotal SEQUOIA-HCM trial continued to favor aficamten, supporting a potential role for another cardiac myosin inhibitor in obstructive hypertrophic cardiomyopathy (HCM). In these randomized.
Journal of Cardiothoracic Surgery
SEPTEMBER 30, 2024
Patients can develop de novo malignancies following orthotopic heart transplantation. However, vascular tumors are not commonly described in this population.
HCPLive
SEPTEMBER 30, 2024
New data presented by Sun Pharma at EADV 2024 highlight the impact of deuruxolitinib 8 mg treatment of adults with severe alopecia areata.
American College of Cardiology
SEPTEMBER 30, 2024
The goal of the LIBerate-HR trial was to evaluate lerodalcibep compared with placebo among patients with increased risk of cardiovascular disease (CVD). Lerodalcibep blocks PCSK9 binding to low-density lipoprotein (LDL)-receptors, thus preventing receptor degradation, which enhances LDL-C clearance and lowering of LDL-C levels.
HCPLive
SEPTEMBER 30, 2024
Bau explains the challenges of using MELD to determine liver transplant referrals and other complexities of the evaluation process.
American College of Cardiology
SEPTEMBER 30, 2024
What is the association of mineralocorticoid receptor antagonist (MRA) use in clinical trials of patients with heart failure (HF) across the left ventricular ejection fraction (EF) spectrum?
HCPLive
SEPTEMBER 30, 2024
The latest episode of Lungcast explores the evolving field of pulmonary imaging technology and the transformative impact of artificial intelligence.
American College of Cardiology
SEPTEMBER 30, 2024
What is the impact of delayed remote ischemic preconditioning (RIPC) on the occurrence of acute kidney injury (AKI) and postoperative complications in patients undergoing cardiac surgery?
HCPLive
SEPTEMBER 30, 2024
Positive 120-day data from the phase 2a study of CNP-104 in PBC highlight its efficacy across multiple immunological and clinical measurements
Journal of Cardiothoracic Surgery
SEPTEMBER 30, 2024
Aortic wrapping (AW) has been performed as a less invasive alternative to aortoplasty. However, AW can also cause long-term aortic complications. In this report, we present a rare case of a dissecting aortic a.
AMS Cardiology
SEPTEMBER 30, 2024
Heart disease is a leading cause of death worldwide. However, many cases can be prevented or detected early through regular check-ups. At AMS Cardiology, we believe proactive care is essential for maintaining optimal heart health. Below we’ll discuss the importance of heart screenings , check-ups and cardiac disease prevention and why choosing AMS Cardiology for your care is the right decision.
Journal of Cardiothoracic Surgery
SEPTEMBER 30, 2024
Giant bullous emphysema is characterized by large bullae occupying at least one-third of the hemithorax and leading to compression of the surrounding lung parenchyma. Overdiagnosis can occur because of the aty.
HCPLive
SEPTEMBER 30, 2024
Phentolamine ophthalmic solution 0.75% effectively reversed pharmacologically-induced pupil dilation in the MIRA-2 and MIRA-3 clinical trials.
Journal of Cardiothoracic Surgery
SEPTEMBER 30, 2024
Atrial septal defect (ASD) is a common congenital heart disease, and currently, transcatheter intervention is the most common clinical treatment method. However, certain complications still occur during the pe.
HCPLive
SEPTEMBER 30, 2024
In other populations, JAKis demonstrated at least a similar pain benefit to b/tsDMARDs from baseline.
Open Heart
SEPTEMBER 30, 2024
Aims To assess the diagnostic accuracy of dobutamine stress echocardiography (DSE) in symptomatic patients with a low to intermediate pretest probability of obstructive coronary artery disease (CAD) and a positive coronary CT angiography (CCTA). Methods We prospectively enrolled 104 consecutive patients undergoing coronary angiography for symptoms of stable CAD and a CCTA indicative of obstructive CAD.
HCPLive
SEPTEMBER 30, 2024
Medical experts discuss the significance of speed in achieving itch relief when choosing a treatment for atopic dermatitis.
Open Heart
SEPTEMBER 30, 2024
Background Patients with shock treated by emergency medical services (EMS) have high morbidity and mortality. Knowledge of prehospital factors predicting outcomes in patients with shock remains limited. We aimed to describe the prehospital predictors of mortality in patients with non-traumatic shock transported to hospital by EMS. Method This is a retrospective cohort study of consecutive ambulance attendances for non-traumatic shock in Victoria, Australia (January 2015–June 2019) linked w
HCPLive
SEPTEMBER 30, 2024
Medical experts evaluate the role of biologics in atopic dermatitis, including their efficacy and safety, and discuss reasons for switching between systemic treatments.
MIBHS
SEPTEMBER 30, 2024
Congenital heart defects (CHDs) are the most common type of birth defect, affecting nearly 1 in 100 newborns. These structural abnormalities of the heart are present at birth. They can range from simple issues that require minimal or no treatment to complex conditions that necessitate multiple surgeries and lifelong care. For families, the journey from diagnosis to treatment and beyond is often filled with uncertainty, emotional strain, and complex decisions.
Expert insights. Personalized for you.
130 
Let's personalize your content